mTOR: a pharmacologic target for autophagy regulation

YC Kim, KL Guan - The Journal of clinical investigation, 2015 - Am Soc Clin Investig
mTOR, a serine/threonine kinase, is a master regulator of cellular metabolism. mTOR
regulates cell growth and proliferation in response to a wide range of cues, and its signaling …

Autophagy—a key player in cellular and body metabolism

KH Kim, MS Lee - Nature Reviews Endocrinology, 2014 - nature.com
Abstract Knowledge gained over the past 10 years about the mechanisms that underpin
autophagy has provided a universal framework for studies of diverse physiological and …

mTOR pathways in cancer and autophagy

M Paquette, L El-Houjeiri, A Pause - Cancers, 2018 - mdpi.com
TOR (target of rapamycin), an evolutionarily-conserved serine/threonine kinase, acts as a
central regulator of cell growth, proliferation and survival in response to nutritional status …

mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability

N Gremke, P Polo, A Dort, J Schneikert… - Nature …, 2020 - nature.com
Cancer cells have a characteristic metabolism, mostly caused by alterations in signal
transduction networks rather than mutations in metabolic enzymes. For metabolic drugs to …

Senescence and aging: the critical roles of p53

A Rufini, P Tucci, I Celardo, G Melino - Oncogene, 2013 - nature.com
Abstract p53 functions as a transcription factor involved in cell-cycle control, DNA repair,
apoptosis and cellular stress responses. However, besides inducing cell growth arrest and …

[HTML][HTML] Role of apoptosis in disease

B Favaloro, N Allocati, V Graziano, C Di Ilio… - Aging (Albany …, 2012 - ncbi.nlm.nih.gov
Since the initial description of apoptosis, a number of different forms of cell death have been
described. In this review we will focus on classic caspase-dependent apoptosis and its …

[HTML][HTML] The effects of metformin on autophagy

G Lu, Z Wu, J Shang, Z Xie, C Chen - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Metformin is the first-line option for treating newly diagnosed diabetic patients and also
involved in other pharmacological actions, including antitumor effect, anti-aging effect …

Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma

K Liu, T Ren, Y Huang, K Sun, X Bao, S Wang… - Cell Death & …, 2017 - nature.com
The cure rate of osteosarcoma has not improved in the past 30 years. The search for new
treatments and drugs is urgently needed. Apatinib is a high selectivity inhibitor of vascular …

Metformin: A review of potential mechanism and therapeutic utility beyond diabetes

S Dutta, RB Shah, S Singhal, SB Dutta… - Drug Design …, 2023 - Taylor & Francis
Metformin has been designated as one of the most crucial first-line therapeutic agents in the
management of type 2 diabetes mellitus. Primarily being an antihyperglycemic agent …

Anticancer activity of metformin: a systematic review of the literature

M Aljofan, D Riethmacher - Future science OA, 2019 - Taylor & Francis
Background: The anticancer activity of metformin has been confirmed against several cancer
types in vitro and in vivo. However, the underlying mechanisms of metformin in the treatment …